Home > Insider Trading > Filing (0001354488-16-008600)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
34956	Tenax Therapeutics Inc.	TENX	Services-Commercial Physical & Biological Research (8731)	262593535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1279191	T Gerald Proehl	C/O Tenax Therapeutics, Inc. One Copley Parkway, Suite 490 Morrisville NC 27560		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-22	15,433	$1.59	15,433	No	4	P	Direct
Common Stock	Acquisiton	2016-11-23	14,449	$1.76	29,882	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.52 to $1.65. The reporting person undertakes to provide to Tenax Therapeutics, Inc. (the "Company"), any security holder of the Company, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.73 to $1.79.